American journal of clinical pathology
-
Am. J. Clin. Pathol. · Oct 2013
CD90 is a diagnostic marker to differentiate between malignant pleural mesothelioma and lung carcinoma with immunohistochemistry.
To pathologically distinguish mesothelioma from lung carcinoma, particularly adenocarcinoma. ⋯ These data collectively indicate that CD90 is a novel diagnostic marker that contributes to a diagnosis of epithelioid mesothelioma.